Bronchial Neoplasm Benign

ELISA assays and Westren blot analysis of survivin and fibulin-3 expression

Survivin and Fibulin-3 in Benign and Malignant Respiratory Diseases

Circulating and Local Expression Levels of Survivin and Fibulin-3 in Benign and Malignant Respiratory Diseases

find out the possible correlations between them and their utility in diagnosing and discriminating malignant from benign lesions that affect the respiratory tract.

Mohammed H. Hassan

Associate Professor of Medical Biochemistry, Faculty of Medicine , South Valley University

South Valley University

Pleural fluid attained during drainage of indwelling pleural catheter

Malignant Pleural Effusions

Johns Hopkins University

Biomarker Levels During Indwelling Pleural cAtheter Sample Testing

TGF-B as a Marker of Pleurodesis in Patients With Tunneled Pleural Catheters

Duration of follow-up will be 12 weeks. After 12 weeks, all patients who do not achieve spontaneous pleurodesis will adhere to the standard drainage protocol.

To determine the threshold TGF-B level to determine accuracy of predicting auto-pleurodesis

Patients randomized to the aggressive intravenous hydration group receive lactated ringers (LR) IV at 3 mL kg-1 hr-1 during the procedure, a 20cc/kg LR IV bolus immediately afterward, and LR IV at 3 mL kg-1 hr-1 for 8 hours following the procedure.

Those in the control arm receive standard fluids defined as LR at 1.5 mL kg-1 hr-1 during the procedure and for 8 hours afterwards.

Pancreatitis

Patients in the intravenous hydration group wll be treated with lactated ringer infusion at a rate of 3cc/kg/hour during the procedure, be given a bolus of 20cc/kg immediately afterward and receive an infusion of 3cc/kg/hour for 8 hours after the procedure.

Aggressive Intravenous Hydration Group

Patients randomized to the standard fluids arm will receive lactated ringers at an infusion rate of 1.5cc/kg/hour during the procedure, will receive no bolus, and will receive an infusion of lactated ringers at 1.5cc/kg for 8 hours after the procedure.

Standard Fluids Arm

Los Angeles County Hospital

Randomized Trial of Aggressive Fluid Hydration to Prevent Post ERCP Pancreatitis

Feasibility Study of a Randomized Trial of Aggressive Fluid Hydration to Prevent Post ERCP Pancreatitis

The primary endpoint is post ERCP pancreatitis which is defined as increased abdominal pain and a serum amylase level three times the upper limit of normal (3xULN). Increased pain will be defined as an increase in the visual analog pain score compared to the value immediately prior to ERCP

Clinical volume overload will be defined by physical findings of lower extremity edema and pulmonary rales.

Serum amylase three times the upper limit of normal is a secondary outcome measure.

Increased abdominal pain is defined as an increase in abdominal pain based on the visual analogue score following the ERCP compared to the score immediately prior to the ERCP.

pleural effusion/protease

Survivin and Fibulin-3 in Benign and Malignant Respiratory Diseases

Biomarker Levels During Indwelling Pleural cAtheter Sample Testing

Randomized Trial of Aggressive Fluid Hydration to Prevent Post ERCP Pancreatitis

Molecular Profiling of Metastatic Cancer in Pleural Effusion and Ascites

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen